-
1
-
-
0033673642
-
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
-
Jones J, Boorman J, Cann P, Forbes A, Gornborone J, et al. (2000) British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. GUT 47: 1-19.
-
(2000)
GUT
, vol.47
, pp. 1-19
-
-
Jones, J.1
Boorman, J.2
Cann, P.3
Forbes, A.4
Gornborone, J.5
-
2
-
-
38449100398
-
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence
-
Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, et al. (2007) Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. GUT 56: 1-113.
-
(2007)
GUT
, vol.56
, pp. 1-113
-
-
Williams, J.G.1
Roberts, S.E.2
Ali, M.F.3
Cheung, W.Y.4
Cohen, D.R.5
-
3
-
-
0025353812
-
Epidemiology of irritable bowel syndrome in the United States
-
Sandler RS, (1990) Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 99: 409-15.
-
(1990)
Gastroenterology
, vol.99
, pp. 409-415
-
-
Sandler, R.S.1
-
4
-
-
33846038273
-
Mechanisms of hypersensitivity in IBS and functional disorders
-
Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, et al. (2007) Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motill 19: 62-88.
-
(2007)
Neurogastroenterol Motill
, vol.19
, pp. 62-88
-
-
Azpiroz, F.1
Bouin, M.2
Camilleri, M.3
Mayer, E.A.4
Poitras, P.5
-
5
-
-
33646204796
-
Fundamentals of Neurogastroenterology: Basic Science
-
Grundy D, Al-Chaer ED, Aziz Q, Collins SM, Meiyun KE, et al. (2006) Fundamentals of Neurogastroenterology: Basic Science. Gastroenterology 130(5): 1391-1411.
-
(2006)
Gastroenterology
, vol.130
, Issue.5
, pp. 1391-1411
-
-
Grundy, D.1
Al-Chaer, E.D.2
Aziz, Q.3
Collins, S.M.4
Meiyun, K.E.5
-
6
-
-
1942470635
-
Irritable bowel syndrome: a model of the brain-gut interactions
-
Mulak A, (2004) Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 10(4): 55-62.
-
(2004)
Med Sci Monit
, vol.10
, Issue.4
, pp. 55-62
-
-
Mulak, A.1
-
7
-
-
76849116160
-
A molecular analysis of fecal and mucosal bacterial community in irritable bowel syndrome
-
Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR, et al. (2010) A molecular analysis of fecal and mucosal bacterial community in irritable bowel syndrome. Digestive disease and sciences 5(2): 392-397.
-
(2010)
Digestive Disease and Sciences
, vol.5
, Issue.2
, pp. 392-397
-
-
Codling, C.1
O'Mahony, L.2
Shanahan, F.3
Quigley, E.M.4
Marchesi, J.R.5
-
8
-
-
15744395134
-
A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator
-
Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, et al. (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator. Gastroenterology 28: 580-9.
-
(2005)
Gastroenterology
, vol.28
, pp. 580-589
-
-
Drossman, D.A.1
Morris, C.B.2
Hu, Y.3
Toner, B.B.4
Diamant, N.5
-
9
-
-
0018174715
-
Towards positive diagnosis of the irritable bowel syndrome
-
Manning AP, Thompson WG, Heaton KW, Morris AF, (1978) Towards positive diagnosis of the irritable bowel syndrome. Br Med J 2: 653-4.
-
(1978)
Br Med J
, vol.2
, pp. 653-654
-
-
Manning, A.P.1
Thompson, W.G.2
Heaton, K.W.3
Morris, A.F.4
-
10
-
-
77950519352
-
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review
-
Whitehead WE, Drossman DA, (2006) Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review. Am J Gastroenterol 105: 814-820.
-
(2006)
Am J Gastroenterol
, vol.105
, pp. 814-820
-
-
Whitehead, W.E.1
Drossman, D.A.2
-
12
-
-
28944446372
-
Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
-
Eamonn MMQ (2005) Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chinese J of Digestive Dis. 122-32.
-
(2005)
Chinese J of Digestive Dis.
, pp. 122-132
-
-
Eamonn, M.M.Q.1
-
13
-
-
10644257329
-
Review article: epidemiology and quality of life in functional gastrointestinal disorders
-
Change L, (2004) Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20: 31-9.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 31-39
-
-
Change, L.1
-
14
-
-
32044454665
-
Costs of irritable bowel syndrome in the UK and US
-
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R, (2006) Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 24: 21-37.
-
(2006)
Pharmacoeconomics
, vol.24
, pp. 21-37
-
-
Maxion-Bergemann, S.1
Thielecke, F.2
Abel, F.3
Bergemann, R.4
-
15
-
-
33748561834
-
Irritable bowel syndrome: The burden and unmet needs in Europe
-
Quigley EMM, Bytzer P, Jones R, Mearin F, (2006) Irritable bowel syndrome: The burden and unmet needs in Europe. Digestive and Liver Disease 38: 717-23.
-
(2006)
Digestive and Liver Disease
, vol.38
, pp. 717-723
-
-
Quigley, E.M.M.1
Bytzer, P.2
Jones, R.3
Mearin, F.4
-
16
-
-
0036320081
-
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
-
Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I, (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123: 450-60.
-
(2002)
Gastroenterology
, vol.123
, pp. 450-460
-
-
Tibble, J.A.1
Sigthorsson, G.2
Foster, R.3
Forgacs, I.4
Bjarnason, I.5
-
17
-
-
38849194737
-
Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
-
Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F, (2008) Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 14: 32-9.
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 32-39
-
-
Schoepfer, A.M.1
Trummler, M.2
Seeholzer, P.3
Criblez, D.H.4
Seibold, F.5
-
18
-
-
51849157847
-
Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
-
Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, et al. (2008) Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 46: 1275-80.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 1275-1280
-
-
Otten, C.M.1
Kok, L.2
Witteman, B.J.3
Baumgarten, R.4
Kampman, E.5
-
19
-
-
17144363641
-
Faecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome
-
Silberer H, Kuppers B, Mickisch O, Baniewicz W, Drescher M, et al. (2005) Faecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 51: 117-26.
-
(2005)
Clin Lab
, vol.51
, pp. 117-126
-
-
Silberer, H.1
Kuppers, B.2
Mickisch, O.3
Baniewicz, W.4
Drescher, M.5
-
20
-
-
84874880856
-
An analysis of volatiles in the headspace of the feces of neonates
-
De Lacy Costello B, Ewen R, Ewer AK, Garner CE, Probert CSJ, et al. (2008) An analysis of volatiles in the headspace of the feces of neonates. J Breath Res 2: 37-39.
-
(2008)
J Breath Res
, vol.2
, pp. 37-39
-
-
de Lacy Costello, B.1
Ewen, R.2
Ewer, A.K.3
Garner, C.E.4
Probert, C.S.J.5
-
21
-
-
0347722496
-
A novel method for rapidly diagnosing the causes of diarrhoea
-
Probert CSJ, Jones PRH, Ratcliffe NM, (2004) A novel method for rapidly diagnosing the causes of diarrhoea. GUT 53: 58-61.
-
(2004)
GUT
, vol.53
, pp. 58-61
-
-
Probert, C.S.J.1
Jones, P.R.H.2
Ratcliffe, N.M.3
-
22
-
-
79954530529
-
Solid-phase microextraction and the human fecal VOC metabolome
-
Dixon E, Clubb C, Pittman S, Ammann L, Rasheed Z, et al. (2011) Solid-phase microextraction and the human fecal VOC metabolome. PLoS ONE 6(4): e18471.
-
(2011)
PLoS ONE
, vol.6
, Issue.4
-
-
Dixon, E.1
Clubb, C.2
Pittman, S.3
Ammann, L.4
Rasheed, Z.5
-
23
-
-
79955618774
-
Impact of the synbiotic combination of Lactulose casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in the healthy subjects
-
De Preter V, Ghebretinsea AH, Abrahantes JC, Windey K, Rutgeerts P, et al. (2011) Impact of the synbiotic combination of Lactulose casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in the healthy subjects. Mol Nutr Food Res 55(5): 714-22.
-
(2011)
Mol Nutr Food Res
, vol.55
, Issue.5
, pp. 714-722
-
-
De Preter, V.1
Ghebretinsea, A.H.2
Abrahantes, J.C.3
Windey, K.4
Rutgeerts, P.5
-
24
-
-
34249816158
-
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
-
Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, et al. (2007) Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J 21: 1675-88.
-
(2007)
FASEB J
, vol.21
, pp. 1675-1688
-
-
Garner, C.E.1
Smith, S.2
de Lacy Costello, B.3
White, P.4
Spencer, R.5
-
25
-
-
70350635540
-
Analysis of fecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study
-
Garner CE, Ewer AK, Elasouad K, Power F, Greenwood R, et al. (2009) Analysis of fecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr 49: 559-65.
-
(2009)
J Pediatr Gastroenterol Nutr
, vol.49
, pp. 559-565
-
-
Garner, C.E.1
Ewer, A.K.2
Elasouad, K.3
Power, F.4
Greenwood, R.5
-
26
-
-
70349983866
-
A pilot study of fecal VOC in feces from cholera patients in Bangladesh to determine their utility in disease diagnosis
-
Garner CE, Smith S, Bardhan PK, Ratcliffe NM, Probert CSJ, (2009) A pilot study of fecal VOC in feces from cholera patients in Bangladesh to determine their utility in disease diagnosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 103: 1171-3.
-
(2009)
Transactions of the Royal Society of Tropical Medicine and Hygiene
, vol.103
, pp. 1171-1173
-
-
Garner, C.E.1
Smith, S.2
Bardhan, P.K.3
Ratcliffe, N.M.4
Probert, C.S.J.5
-
27
-
-
0019319257
-
A simple index of Crohn's disease activity
-
Harvey RF, Bradshaw JM, (1980) A simple index of Crohn's disease activity. The Lancet 315: 514-6.
-
(1980)
The Lancet
, vol.315
, pp. 514-516
-
-
Harvey, R.F.1
Bradshaw, J.M.2
-
28
-
-
0029047515
-
Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification
-
Seo M, Okada M, Yao T, Okabe N, Maeda K, et al. (1995) Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification. Am J Gastroenterol 90(10): 1759-63.
-
(1995)
Am J Gastroenterol
, vol.90
, Issue.10
, pp. 1759-1763
-
-
Seo, M.1
Okada, M.2
Yao, T.3
Okabe, N.4
Maeda, K.5
-
30
-
-
0000859675
-
An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion
-
Stone M, (1977) An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. Journal of the Royal Statistical Society Series B (Methodological) 39: 44-7.
-
(1977)
Journal of the Royal Statistical Society Series B (Methodological)
, vol.39
, pp. 44-47
-
-
Stone, M.1
-
31
-
-
75349109603
-
Elevated pro-inflammatory and Lipotoxic mucosal lipids chracterise irritable bowel syndrome
-
Kajander K, Myllyluoma E, Kyronpalo S, Rasmussen M, Sipponen P, et al. (2009) Elevated pro-inflammatory and Lipotoxic mucosal lipids chracterise irritable bowel syndrome. World J Gasteroenterol 14: 6068-74.
-
(2009)
World J Gasteroenterol
, vol.14
, pp. 6068-6074
-
-
Kajander, K.1
Myllyluoma, E.2
Kyronpalo, S.3
Rasmussen, M.4
Sipponen, P.5
-
32
-
-
77950670562
-
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
-
Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, et al. (2010) Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterology & Motility 22(5): 512-9.
-
(2010)
Neurogastroenterology & Motility
, vol.22
, Issue.5
, pp. 512-519
-
-
Tana, C.1
Umesaki, Y.2
Imaoka, A.3
Handa, T.4
Kanazawa, M.5
-
33
-
-
0018816521
-
Degradation of organic acids by dairy lactic acid bacteria
-
Hegazi FZ Abo-EInaga IG, (1980) Degradation of organic acids by dairy lactic acid bacteria. Zentralbl Bakteriol Naturwiss 135(3): 212-22.
-
(1980)
Zentralbl Bakteriol Naturwiss
, vol.135
, Issue.3
, pp. 212-222
-
-
Hegazi, F.Z.1
Abo-EInaga, I.G.2
-
34
-
-
0031453130
-
Comparison of batch culture growth and fermentation of a poultry veillonella isolate and selected veillonella species grown in a defined medium
-
Durant JA, Nisbet DJ, Ricke SC, (1997) Comparison of batch culture growth and fermentation of a poultry veillonella isolate and selected veillonella species grown in a defined medium. Anaerobe 3: 391-7.
-
(1997)
Anaerobe
, vol.3
, pp. 391-397
-
-
Durant, J.A.1
Nisbet, D.J.2
Ricke, S.C.3
-
35
-
-
84872754649
-
High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro
-
Shen Q, Zhao L, Tuohy K, (2011) High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro. European Journal of Nutrition pp. 1-13.
-
(2011)
European Journal of Nutrition
, pp. 1-13
-
-
Shen, Q.1
Zhao, L.2
Tuohy, K.3
-
36
-
-
7244231035
-
Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers
-
Gonlachanvit S, Coleski R, Owyang C, Hasler W, (2004) Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers. GUT 53(11): 1577-82.
-
(2004)
GUT
, vol.53
, Issue.11
, pp. 1577-1582
-
-
Gonlachanvit, S.1
Coleski, R.2
Owyang, C.3
Hasler, W.4
-
37
-
-
37149033981
-
Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae
-
Elia M, Engfer MB, Green CJ, Silk DB, (2008) Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther 27: 120-45.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 120-145
-
-
Elia, M.1
Engfer, M.B.2
Green, C.J.3
Silk, D.B.4
-
38
-
-
0030731874
-
Absence of gaseous symptoms during ingestion of commercial fibre preparations
-
Zumarraga L, Suarez F, (1997) Absence of gaseous symptoms during ingestion of commercial fibre preparations. Aliment Pharmacol Ther 11: 1067-72.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 1067-1072
-
-
Zumarraga, L.1
Suarez, F.2
-
39
-
-
80054983182
-
Comparison of symptom response following advice for a diet low in fermentable (FODMAP) carbohydrates versus standard dietary advice in patients with IBS
-
Staudacher HM, Whelan K, Irving PM, Lorner MC, (2011) Comparison of symptom response following advice for a diet low in fermentable (FODMAP) carbohydrates versus standard dietary advice in patients with IBS. J Hum Nutr Diet 24(5): 487-95.
-
(2011)
J Hum Nutr Diet
, vol.24
, Issue.5
, pp. 487-495
-
-
Staudacher, H.M.1
Whelan, K.2
Irving, P.M.3
Lorner, M.C.4
-
40
-
-
77954907393
-
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in IBS
-
Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in IBS. J Gastroenterol Hepatol 25(8): 1366-73.
-
J Gastroenterol Hepatol
, vol.25
, Issue.8
, pp. 1366-1373
-
-
Ong, D.K.1
Mitchell, S.B.2
Barrett, J.S.3
Shepherd, S.J.4
Irving, P.M.5
-
41
-
-
77649299288
-
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
-
Reddymasu S, Sostarich S, McCallum R, (2010) Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterology 10: 23.
-
(2010)
BMC Gastroenterology
, vol.10
, pp. 23
-
-
Reddymasu, S.1
Sostarich, S.2
McCallum, R.3
-
42
-
-
0037286459
-
Methane production during lactulose breath test is associated with gastrointestinal disease presentation
-
Pimentel M, Mayer A, Park S, Chow EJ, Hasan A, et al. (2003) Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 48: 86-92.
-
(2003)
Dig Dis Sci
, vol.48
, pp. 86-92
-
-
Pimentel, M.1
Mayer, A.2
Park, S.3
Chow, E.J.4
Hasan, A.5
-
43
-
-
84863425462
-
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation
-
Furnari M, Savarino V, Bruzzone L, Moscatelli A, Gemignani L, et al. (2012) Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis 21: 157-63.
-
(2012)
J Gastrointestin Liver Dis
, vol.21
, pp. 157-163
-
-
Furnari, M.1
Savarino, V.2
Bruzzone, L.3
Moscatelli, A.4
Gemignani, L.5
-
44
-
-
0032895676
-
Breath alkanes determination in ulcerative colitis and Crohn's disease
-
Pelli MA, Trovarelli G, Capodicasa E, De Medio GE, Bassotti G, et al. (1999) Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum (421) (): 71-6.
-
(1999)
Dis Colon Rectum
, vol.42
, Issue.1
, pp. 71-76
-
-
Pelli, M.A.1
Trovarelli, G.2
Capodicasa, E.3
De Medio, G.E.4
Bassotti, G.5
-
45
-
-
49349114912
-
Can calprotectin predict relapse risk in inflammatory bowel disease?
-
D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, et al. (2008) Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol103: 2007-14.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2007-2014
-
-
D'Incà, R.1
Dal Pont, E.2
Di Leo, V.3
Benazzato, L.4
Martinato, M.5
-
46
-
-
33745262396
-
Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
-
Konikoff MR, Denson LA, (2006) Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12: 524-34.
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 524-534
-
-
Konikoff, M.R.1
Denson, L.A.2
-
47
-
-
57449085396
-
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
-
Gisbert JP, McNicholl AG, (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 41: 56-66.
-
(2009)
Digestive and Liver Disease
, vol.41
, pp. 56-66
-
-
Gisbert, J.P.1
McNicholl, A.G.2
-
48
-
-
33746107621
-
Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy
-
Garcia Sanchez V, Gonzalez R, Iglesias Flores E, Gomes Camacho F, Casais Juanena L, et al. (2006) Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy. Med Clin (Barc) 127: 41-6.
-
(2006)
Med Clin (Barc)
, vol.127
, pp. 41-46
-
-
Garcia Sanchez, V.1
Gonzalez, R.2
Iglesias Flores, E.3
Gomes Camacho, F.4
Casais Juanena, L.5
-
49
-
-
77952104443
-
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
-
García-Sánchez V, Iglesias-Flores E, González R, Gisbert JP, Gallardo-Valverde JM, et al. (2010) Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J Crohns Colitis 4: 144-52.
-
(2010)
J Crohns Colitis
, vol.4
, pp. 144-152
-
-
García-Sánchez, V.1
Iglesias-Flores, E.2
González, R.3
Gisbert, J.P.4
Gallardo-Valverde, J.M.5
-
50
-
-
14544308315
-
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
-
Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, et al. (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. GUT 54(3): 364-8.
-
(2005)
GUT
, vol.54
, Issue.3
, pp. 364-368
-
-
Costa, F.1
Mumolo, M.G.2
Ceccarelli, L.3
Bellini, M.4
Romano, M.R.5
-
51
-
-
84859635560
-
Faecal markers: calprotectin and lactoferrin
-
Abraham BP, (2012) Faecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am 41: 483-95.
-
(2012)
Gastroenterol Clin North Am
, vol.41
, pp. 483-495
-
-
Abraham, B.P.1
-
52
-
-
33750480850
-
Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
-
Schlotterbeck G, Ross A, Dieterle F, Senn H, (2006) Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics 7: 1055-75.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 1055-1075
-
-
Schlotterbeck, G.1
Ross, A.2
Dieterle, F.3
Senn, H.4
-
53
-
-
42649087443
-
Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry
-
Xue R, Dong L, Zhang S, Deng C, Liu T, et al. (2008) Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22: 1181-6.
-
(2008)
Rapid Commun Mass Spectrom
, vol.22
, pp. 1181-1186
-
-
Xue, R.1
Dong, L.2
Zhang, S.3
Deng, C.4
Liu, T.5
-
54
-
-
0037709680
-
Detection of lung cancer with volatile markers in the breath
-
Phillips M, Cataneo RN, Cummin ARC, Gagliardi AJ, Gleeson K, et al. (2003) Detection of lung cancer with volatile markers in the breath. Chest 123: 2115-23.
-
(2003)
Chest
, vol.123
, pp. 2115-2123
-
-
Phillips, M.1
Cataneo, R.N.2
Cummin, A.R.C.3
Gagliardi, A.J.4
Gleeson, K.5
-
55
-
-
0037736535
-
Volatile markers of breast cancer in the breath
-
Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, et al. (2003) Volatile markers of breast cancer in the breath. The Breast Journal 9: 184-91.
-
(2003)
The Breast Journal
, vol.9
, pp. 184-191
-
-
Phillips, M.1
Cataneo, R.N.2
Ditkoff, B.A.3
Fisher, P.4
Greenberg, J.5
-
56
-
-
73949103289
-
Volatile organic compounds in the diagnosis of gastrointestinal and liver disease. J Gastrointestin Liver Dis
-
Probert CS. Ahmed I, Khalid T, Johnson E, Smith S, et al. (2009) Volatile organic compounds in the diagnosis of gastrointestinal and liver disease. J Gastrointestin Liver Dis. 18(3): 337-43.
-
(2009)
, vol.18
, Issue.3
, pp. 337-343
-
-
Probert, C.S.1
Ahmed, I.2
Khalid, T.3
Johnson, E.4
Smith, S.5
-
57
-
-
33746819836
-
Metabolomic approaches to phenotype characterization and application to complex disease
-
Oresic M, Vidal-Puig A, Hanninen V, (2006) Metabolomic approaches to phenotype characterization and application to complex disease. Expert review of molecular diagnostics 6: 575-85.
-
(2006)
Expert Review of Molecular Diagnostics
, vol.6
, pp. 575-585
-
-
Oresic, M.1
Vidal-Puig, A.2
Hanninen, V.3
|